Muthusamy Shanmugam - 15 Jul 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF R&D, COO-NOVITIUM OPS, Director
Signature
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
15 Jul 2024
Net transactions value
-$3,011,592
Form type
4
Filing time
17 Jul 2024, 19:07:47 UTC
Previous filing
24 Jun 2024
Next filing
19 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $697,180 -11,000 -1.6% $63.38 671,620 15 Jul 2024 Held by Esjay LLC F1, F2, F3
transaction ANIP Common Stock Sale $1,413,940 -22,000 -3.3% $64.27 649,620 16 Jul 2024 Held by Esjay LLC F1, F3, F4
transaction ANIP Common Stock Sale $900,472 -14,257 -2.2% $63.16 635,363 17 Jul 2024 Held by Esjay LLC F1, F3, F5
holding ANIP Common Stock 68,652 15 Jul 2024 Direct
holding ANIP Common Stock 5,000 15 Jul 2024 Held by SS Pharma LLC F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023.
F2 The shares were sold in multiple trades at prices ranging from $62.47 to $64.19. The price reported above reflects the weighted average sales price.
F3 The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F4 The shares were sold in multiple trades at prices ranging from $63.25 to $64.91. The price reported above reflects the weighted average sales price.
F5 The shares were sold in multiple trades at prices ranging from $62.62 to $64.21. The price reported above reflects the weighted average sales price.
F6 The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.